Macquarie Group’s Immunomedics Inc IMMU Stock Holding History

Macquarie Group’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-196,834	Closed	-$16.7M	–	2405
2020 Q3	$16.7M	Sell	196,834 -86,663	-31%	-$4.38M	0.03%	526
2020 Q2	$10M	Buy	283,497 +47,444	+20%	+$1.39M	0.02%	630
2020 Q1	$3.18M	Sell	236,053 -285,305	-55%	-$4.8M	0.01%	818
2019 Q4	$11M	Sell	521,358 -142,526	-21%	-$2.51M	0.02%	628
2019 Q3	$8.8M	Buy	663,884 +83,884	+14%	+$1.23M	0.01%	629
2019 Q2	$8.04M	Sell	580,000 -280,000	-33%	-$4.21M	0.01%	656
2019 Q1	$16.5M	Buy	+860,000	New	+$13.9M	0.03%	513

Macquarie Group's IMMU Position: Q4 2020 in Review

Macquarie Group sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 196,834 shares — an estimated $16.7M sold.

Macquarie Group first reported a position in IMMU in Q1 2019 and held it in 7 quarters. The position peaked at $16.7M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

Macquarie Group reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
Macquarie Group sold 196,834 Immunomedics Inc shares in Q4 2020, an estimated $16.7M.
Macquarie Group first reported a position in Immunomedics Inc in Q1 2019 and held it in 7 quarters.
Macquarie Group's Immunomedics Inc position peaked at $16.7M in Q3 2020.
0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Macquarie Group's 13F filing for Q4 2020, filed 16 Feb 2021.